Page last updated: 2024-12-08

6-hydroxyindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-hydroxyindole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID524508
CHEMBL ID2413822
SCHEMBL ID34240
MeSH IDM0572534

Synonyms (43)

Synonym
AC-3115
6-hydroxyindole
2380-86-1
H-6060
1h-indol-6-ol
FT-0658916
A4967
AKOS005257328
unii-3i03jz599t
ec 417-020-4
3i03jz599t ,
indol-6-ol
6-hydroxy indole
indolol
6-indolol
6-hydroxy-1h-indole
S3315
BP-10186
FT-0601264
PS-5925
AM20030416
AB04037
CHEMBL2413822 ,
imexine oba
6-hydroxyindole [inci]
1h-indole-6-ol
6hydroxyindole
6-hydroxy-indole
SCHEMBL34240
SY003879
mfcd00152101
F60 ,
DTXSID20178497
CS-W002438
6-hydroxyindole, >=99.0% (gc)
bdbm50559085
BCP26511
Q27257236
indol-6-ol (6ci,7ci,8ci)
EN300-114845
PD144383
HY-W002438
Z1203162244

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The Panel considered relevant animal and human data provided in this safety assessment and concluded that 6-hydroxyindole is safe for use in oxidative hair dye formulations."( Safety assessment of 6-hydroxyindole as used in cosmetics.
Andersen, FA; Belsito, DV; Bergfeld, WF; Burnett, CL; Heldreth, B; Hill, RA; Klaassen, CD; Liebler, DC; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW,
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TyrosinaseHomo sapiens (human)IC50 (µMol)22.00000.02304.459310.0000AID1717725
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1E1Homo sapiens (human)Km2,713.00001.60004.63676.4000AID1639874
Sulfotransferase 1A1Homo sapiens (human)Km0.23000.17001.83436.6200AID1639868
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (22)

Processvia Protein(s)Taxonomy
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
sulfationSulfotransferase 1E1Homo sapiens (human)
ethanol catabolic processSulfotransferase 1E1Homo sapiens (human)
estrogen catabolic processSulfotransferase 1E1Homo sapiens (human)
steroid metabolic processSulfotransferase 1E1Homo sapiens (human)
estrogen metabolic processSulfotransferase 1E1Homo sapiens (human)
positive regulation of fat cell differentiationSulfotransferase 1E1Homo sapiens (human)
3'-phosphoadenosine 5'-phosphosulfate metabolic processSulfotransferase 1E1Homo sapiens (human)
sulfationSulfotransferase 1E1Homo sapiens (human)
sulfationSulfotransferase 1A1Homo sapiens (human)
ethanol catabolic processSulfotransferase 1A1Homo sapiens (human)
catecholamine metabolic processSulfotransferase 1A1Homo sapiens (human)
xenobiotic metabolic processSulfotransferase 1A1Homo sapiens (human)
estrogen metabolic processSulfotransferase 1A1Homo sapiens (human)
amine metabolic processSulfotransferase 1A1Homo sapiens (human)
flavonoid metabolic processSulfotransferase 1A1Homo sapiens (human)
3'-phosphoadenosine 5'-phosphosulfate metabolic processSulfotransferase 1A1Homo sapiens (human)
sulfationSulfotransferase 1A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
estrone sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
steroid bindingSulfotransferase 1E1Homo sapiens (human)
protein bindingSulfotransferase 1E1Homo sapiens (human)
sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
flavonol 3-sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
steroid sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
aryl sulfotransferase activitySulfotransferase 1E1Homo sapiens (human)
aryl sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
protein bindingSulfotransferase 1A1Homo sapiens (human)
sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
flavonol 3-sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
steroid sulfotransferase activitySulfotransferase 1A1Homo sapiens (human)
3'-phosphoadenosine 5'-phosphosulfate bindingSulfotransferase 1A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
cytosolSulfotransferase 1E1Homo sapiens (human)
nuclear membraneSulfotransferase 1E1Homo sapiens (human)
cytoplasmSulfotransferase 1E1Homo sapiens (human)
cytosolSulfotransferase 1A1Homo sapiens (human)
cytoplasmSulfotransferase 1A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1064677Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 33 uM after 20 mins by spectrophotometric analysis2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
AID1717725Inhibition of human HMV-II cell derived tyrosinase using DOPA as substrate incubated for 5 mins by light absorbance method2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
AID763542Antioxidant activity assessed as inhibition of ABTS free radical generation at 17 uM after 20 mins by UV spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.
AID763541Antioxidant activity assessed as inhibition of ABTS free radical generation at 9 uM after 20 mins by UV spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.
AID1064674Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
AID1064675Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 9 uM after 20 mins by spectrophotometric analysis2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (55.56)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.51 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]